Dr. Christine Esau appointed VP of Research and Development for Arcturus Therapeutics

Ace RNA medicines company, Arcturus Therapeutics asserted the appointment of Dr. Christine Esau, Senior Director of Translational Research, as Vice President of Research and Development, effective immediately.

Mark R. Herbert, Interim President said “Given her experience with Arcturus over the past several years, we are confident that in this new role, Christine will immediately contribute to the progress we are making in developing innovative RNA medicines with the potential to transform the lives of patients with serious diseases. We are pleased Dr. Chivukula will serve as a Scientific Advisor to the Company.”

Dr. Chivukula said “It has been a privilege to be a part of the Arcturus team, and I am proud of our extraordinary innovations and accomplishments in advancing our diverse pipeline of RNA therapeutics and the many partnerships we have garnered thus far.”